Abstract
PURPOSE: To determine classification criteria for Behçet disease uveitis.
DESIGN: Machine learning of cases with Behçet disease and 5 other panuveitides.
METHODS: Cases of panuveitides were collected in an informatics-designed preliminary database, and a final database was constructed of cases achieving supermajority agreement on the diagnosis, using formal consensus techniques. Cases were split into a training set and a validation set. Machine learning using multinomial logistic regression was used on the training set to determine a parsimonious set of criteria that minimized the misclassification rate among the intermediate uveitides. The resulting criteria were evaluated on the validation set.
RESULTS: One thousand twelve of cases panuveitides, including 194 cases of Behçet disease with uveitis, were evaluated by machine learning. The overall accuracy for panuveitides was 96.3% in the training set and 94.0% in the validation set (95% confidence interval 89.0, 96.8). Key criteria for Behçet disease uveitis were a diagnosis of Behçet disease using the International Study Group for Behçet Disease criteria and a compatible uveitis, including: 1) anterior uveitis; 2) anterior chamber and vitreous inflammation; 3) posterior uveitis with retinal vasculitis and/or focal infiltrates; or 4) panuveitis with retinal vasculitis and/or focal infiltrates. The misclassification rates for Behçet disease uveitis were 0.6 % in the training set and 0% in the validation set, respectively.
CONCLUSIONS: The criteria for Behçet disease uveitis had a low misclassification rate and appeared to perform sufficiently well for use in clinical and translational research.
| Original language | English |
|---|---|
| Pages (from-to) | 80-88 |
| Number of pages | 9 |
| Journal | American Journal of Ophthalmology |
| Volume | 228 |
| Early online date | 11 May 2021 |
| DOIs | |
| Publication status | Published - Aug 2021 |
Bibliographical note
Funding Information:Funding/Support: Supported by grant R01 EY026593 from the National Eye Institute, National Institutes of Health, Bethesda, Maryland, USA; the David Brown Fund, New York, New York, USA; the Jillian M. and Lawrence A. Neubauer Foundation, New York, New York, USA; and the New York Eye and Ear Foundation, New York, New York, USA.
Publisher Copyright:
© 2021 Elsevier Inc.